Exposure–response analyses of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma

por Dosne, Anne-Gaëlle, Valade, Elodie, Goeyvaerts, Nele, De Porre, Peter, Avadhani, Anjali, O’Hagan, Anne, Li, Lilian Y., Ouellet, Daniele, Perez Ruixo, Juan Jose
Publicado 2022

Erdafitinib’s effect on serum phosphate justifies its pharmacodynamically guided dosing in patients with cancer

por Dosne, Anne‐Gaëlle, Valade, Elodie, Stuyckens, Kim, De Porre, Peter, Avadhani, Anjali, O’Hagan, Anne, Li, Lilian Y., Ouellet, Daniele, Faelens, Ruben, Leirens, Quentin, Poggesi, Italo, Perez Ruixo, Juan Jose
Publicado 2021